Viewing Study NCT00762255

Bugs

Ignite Creation Date: 2025-12-18 @ 6:32 AM

Ignite Modification Date: 2025-12-23 @ 8:46 PM

Study NCT ID: NCT00762255

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module